Bariatric surgery and prophylaxis against symptomatic gallstone disease

This publication has 8 references indexed in Scilit:

• Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial
  The Lancet Gastroenterology & Hepatology, 2021
• Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015–2018
  Obesity Surgery, 2021
• Long-term incidence of gallstone disease after bariatric surgery
  Surgery for Obesity and Related Diseases, 2020
• British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery—2020 update
  Obesity Reviews, 2020
• Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP
  Surgical Endoscopy, 2020
• Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
  BMC Gastroenterology, 2017
• Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management
  Obesity Facts, 2017
• Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy
  Surgical Endoscopy, 2008